Accueil du site > Revue de presse > Sources d’information > Médical > AIDSMeds.com
AIDSMeds.com
http://www.aidsmeds.com/news/TopStories.htm
Fil d’information de Reuters Health (en anglais) sur l’actualité thérapeutique du VIH.
-
Hormonal Contraceptives and HIV Disease Progression
There is a possible link between hormonal contraceptives and faster HIV disease progression, according to a research review article in the October 1 issue of Clinical Infectious Diseases (CID).
-
SMART Study Findings on Abacavir and Cardiovascular Risk
Abacavir (found in Ziagen, Epzicom and Trizivir) is associated with a quadrupled risk of a heart attack in HIV-positive patients using the drug, according to the authors of a study published in the September 12 issue of AIDS.
-
PML Still a Risk and Often Progressive
Even though combination antiretroviral (ARV) therapy effectively reduces the risk and severity of many AIDS-related conditions, progressive multifocal leukoencephalopathy (PML) remains a debilitating and deadly disease for many people living with HIV, according to a study published in the (...)
-
Better HIV Treatment Response Seen in Older Patients
People who become infected with HIV after the age of 30 have a better response to antiretroviral (ARV) therapy than people who become infected at a younger age, according to a study published in the September 1 issue of the Journal of Acquired Immune Deficiency (...)
-
Cases of HIV Detectable in Semen, but Not Blood
Five percent of HIV-positive men in a French study had detectable HIV in their semen even when no HIV was detectable in their blood, say the authors of a study published in the August 20 issue of AIDS.
-
New Drug Interaction Information With Reyataz
The U.S. Food and Drug Administration (FDA) issued new instructions on potential drug interactions between the protease inhibitor Reyataz (atazanavir) and several other types of medications, including antiretroviral drugs, hormonal contraceptives and stomach acid (...)
-
Non-Nukes and Triglyceride Levels Affect HDL Cholesterol
Having an undetectable viral load and taking a regimen including a non-nucleoside reverse transcriptase inhibitor (NNRTI) may protect against unhealthy reductions in “good” HDL cholesterol, according to a study published in the July issue of AIDS Patient Care and (...)
-
Short-term Therapy May Help HIV-Related Depression
A short 20-week course of psychotherapy may improve depression and anxiety symptoms for gay men living with HIV, according to a study in the July issue of AIDS Patient Care and STDs.
-
Rapid Hep C Disease Progression in HIV-Positive Men
Rapid progression of liver disease shortly after becoming infected with hepatitis C virus (HCV), has been documented in a group of HIV-positive gay men, according to a study published in the September 1 issue of The Journal of Infectious (...)
-
AIDS Activism For The Next Decade
Mark Harrington, a long time AIDS activist and the Executive Director of the Treatment Action Group in New York City, predicts the coming challenges in AIDS activism and explains what people with HIV and their allies can do about (...)
